NRx Pharmaceuticals Announces Expansion of ZYESAMI® (aviptadil) US Expanded Access and Right to Try Programs for Patients with COVID-19 Respiratory Failure who have Exhausted All Approved Treatments

NEXT STORY
Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D.
PREV STORY
Global Neurorehabilitation Devices Market to Reach US$2.1 Billion by the Year 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure 

author_avatar
NASDAQ Market News

Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins Researchers Demonstrates Potential of Next-Generation Sequencing for Investigation of Genetic Antimicrobial Resistance Mechanisms and Molecular Susceptibility Testing

author_avatar
NASDAQ Market News

Castle Rock Veterinarian Brekke Veterinary Clinic Reminds Pet Owners About Heartworm Risk During Heartworm Awareness Month

CASTLE ROCK, Colo., April 23, 2017 (GLOBE NEWSWIRE) -- April is Heartworm Awareness Month ...

author_avatar
NASDAQ Market News